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Abstract
Background: In-vitro fertilization (IVF) with blastocyst as opposed to cleavage stage embryos has been
advocated to improve success rates. Limited information exists on which to predict which patients
undergoing blastocyst embryo transfer (BET) will achieve pregnancy. This study's objective was to evaluate
the predictive value of patient and cycle characteristics for clinical pregnancy following fresh BET.
Methods: This was a retrospective cohort study from 2003–2007 at an academic assisted reproductive
program. 114 women with infertility underwent fresh IVF with embryo transfer. We studied patients
undergoing transfer of embryos at the blastocyst stage of development. Our main outcome of interest was
clinical pregnancy. Clinical pregnancy and its associations with patient characteristics (age, body mass
index, FSH, ethnicity) and cycle parameters (thickness of endometrial stripe, number eggs, available
cleaving embryos, number blastocysts available, transferred, and cryopreserved, and embryo quality) were
examined using Student's T test and Mann-Whitney-U tests as appropriate. Multivariable logistic
regression models were created to determine independent predictors of CP following BET. Receiver
Operating Characteristic analyses were used to determine the optimal thickness of endometrial stripe for
predicting clinical pregnancy.
Results:  Patients achieving clinical pregnancy demonstrated a thicker endometrial stripe and were
younger preceding embryo transfer. On multivariable logistic regression analyses, Caucasian ethnicity (OR
2.641, 95% CI 1.054–6.617), thickness of endometrial stripe, (OR 1.185, 95% CI 1.006–1.396) and age (OR
0.879, 95% CI 0.789–0.980) predicted clinical pregnancy. By receiver operating characteristic analysis,
endometrial stripe ≥ 9.4 mm demonstrated a sensitivity of 83% for predicting clinical pregnancy following
BET.
Conclusion: In a cohort of patients undergoing fresh BET, thicker endometrial stripe, Caucasian ethnicity,
and younger age are positive predictors of clinical pregnancy after fresh BET. These findings may be useful
in clinical management of infertile patients undergoing fresh BET cycles.
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Background
Technical advances in assisted reproductive technologies
(ART) have led to improving pregnancy rates with in-vitro
fertilization (IVF). Traditionally following controlled
ovarian hyperstimulation (COH) and oocyte retrieval,
cleaving embryos have been transferred 2–3 days after fer-
tilization; over the last decade, improvements in labora-
tory techniques and embryo culture media have allowed
successful in vitro culture of embryos to the blastocyst
stage. Blastocyst embryo transfer (BET) has been shown to
correlate to higher live birth rates[1]. Higher success rates
with BET may reflect an enhanced natural selection proc-
ess that allows for biologically superior embryos to be
transferred, rather than relying on morphological assess-
ment of cleavage stage embryos [2]. Alternatively,
improved pregnancy rates with BET may reflect a more
synchronous environment between the blastocyst and the
endometrium as blastocyst-endometrial interactions are
an essential part of implantation [3]. Valbuena et al [4]
have suggested that higher detrimental estradiol levels at
the time of cleavage embryo transfer compared to the later
timing of the blastocyst transfer, may also contribute to
the differential pregnancy rates seen. Finally, it has been
proposed that decreasing uterine contractility each day
following oocyte retrieval may reduce embryo displace-
ment inside the uterus and improve pregnancy success
with blastocyst embryos [5].
A large body of retrospective data first suggested higher
clinical pregnancy rates after BET. In one of the larger
studies, Schwarzler et al. [6] showed clinical pregnancy
rates of 44% after blastocyst and 28% after cleavage stage
transfer. A prospective, randomized study of single
embryo transfer showed high pregnancy rates (33% vs.
23%) after BET in patients with high embryo quality (6–8
cells, <25% fragmentation, and even-numbered blast-
omeres), proposed to be from natural selection of the best
embryos[7]. Papanikolaou et al. [8] in a prospective rand-
omized study showed both higher clinical pregnancy rate
(58% vs. 41%) and lower pregnancy loss rate (14% vs.
20%) after single embryo transfer at the blastocyst versus
cleavage stage, postulated to be due to lower rates of ane-
uploidy. A recent Cochrane meta-analysis including nine
randomized control trials showed higher live birth rates in
blastocyst cycles (OR 1.35, 95% CI 1.05 – 1.74) with no
difference in miscarriage or multiple pregnancy rates[1].
The authors suggest this may be due to either natural
selection of the 'best embryo' or due to a difference in the
interactions between the embryo and uterine environ-
ment.
Although these studies have suggested that it is primarily
embryological characteristics (i.e. higher number of
embryos at the 6–8 cell stage, high quality embryos) that
predict the successful development of a blastocyst, a sys-
tematic assessment of predictors of successful clinical out-
come after BET cycles is lacking. Many articles have
examined the ability of embryos to develop to the blasto-
cyst stage and subsequently impact pregnancy rate.
Almost none have reported on the ability to differentially
predict pregnancy rates once a patient has already devel-
oped blastocysts [1]. In one of the larger studies, which
examined single blastocyst transfer and where more than
95% of patients received a good quality blastocyst (thus
providing a more controlled environment to adjust for
embryo factors), no predictive factors were reported
within the blastocyst group [8]. In one of the only studies
which have reported predictive factors, Richter et al. dem-
onstrated that age, embryo quality, and endometrial
thickness were related to clinical pregnancy [9]. Our
objective in this study was to identify patient and COH
cycle characteristics that may impact on the probability of




All IVF cycles between 2003 and 2007 at Montefiore's
Institute for Reproductive Medicine and Health (MIRMH)
were reviewed. Data were collected from patient charts,
computerized ultrasound reports, completed patient
intake questionnaires including information on racial and
ethnic background, and detailed embryology records.
Analyses were restricted to all fresh IVF cycles proceeding
to BET (n = 114). IVF cycles utilizing donor oocytes and
thawed BET cycles were excluded; ART cycles utilizing pre-
implantation genetic screening or diagnosis were
included (n = 4). Early follicular phase (cycle days 1–3)
serum levels of FSH reflected "ovarian reserve" status [10];
for those patients in whom prior FSH values were availa-
ble, the highest available level was taken to reflect ovarian
reserve for the individual.
Patient management was per routine clinical practice, and
all patient stimulation protocols were reviewed and
approved by a single clinical director. Ovulation suppres-
sion was achieved with either GnRH agonists or antago-
nists; COH was achieved with injectable gonadotropins
and transvaginal ultrasound guided oocyte retrieval was
performed 34 hours after hCG injection. Patients met cri-
teria for hCG injection when 2 follicles (mean diameter)
were >17 mm. All patients received luteal supplementa-
tion with intramuscular progesterone in oil. During the
study period, there were no major changes in laboratory
personnel or protocols. IVF (n = 48), intracytoplasmic
sperm injection (ICSI)(n = 51), and Split cycles (partial
IVF/partial ICSI) (n = 15) cycles were included. The deci-
sion to proceed to BET was based on the number and
cleavage status of available embryos 2 days post insemina-
tion; patients with at least six four-cell embryos (<20%Reproductive Biology and Endocrinology 2009, 7:33 http://www.rbej.com/content/7/1/33
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fragmentation) that continued to divide were taken to the
blastocyst stage. Patients age >35 were additionally taken
to blastocyst culture if they failed to achieve CP in a prior
ART cycle using cleavage stage embryos (n = 19). Out-
come of interest was CP, defined by the presence of an
intrauterine gestational sac on trans-vaginal ultrasound.
All other cycle outcomes (non-pregnant, biochemical,
and ectopic pregnancies) were classified as negative preg-
nancy (NP).
The study was approved by the Institutional Review Board
at Montefiore Medical Center, Bronx, New York. Given
the retrospective nature of analyses, written informed con-
sent was waived.
Statistical analysis
Distribution of continuous variables was assessed by Sha-
piro-Wilk test. Associations of CP with patient characteris-
tics (age, body-mass index (BMI), FSH, ethnicity) and ART
cycle parameters (serum E2 levels on day of hCG, maximal
cycle thickness of endometrial stripe-ES on day of hCG,
number of eggs retrieved, number of mature (metaphase
2) eggs, number of fertilized embryos, available cleaving
embryos on Day 2 and 3, number of blastocysts available,
transferred, and cryopreserved) were evaluated using Stu-
dent's T test (for data demonstrating Gaussian distribu-
tion) or the Mann-Whitney tests (for skewed data) as
appropriate. Spearman's correlation analyses evaluated
associations between the various patient and cycle param-
eters. Fertilization % (% of mature eggs fertilized) by fer-
tilization method (IVF, ICSI, Split) was evaluated by
ANOVA. Multivariable logistic regression models report-
ing odds ratios (OR) ± 95% confidence intervals were cre-
ated to determine independent predictors of CP following
BET as well as to examine the relationship between weight
and Caucasian ethnicity. Additionally, the influence of
fertilization method on CP was evaluated by chi-squared
test (χ2). Embryo quality was defined according to our
standard assessment practices[11]. Embryo quality was
categorized according to the criteria set forth by the Soci-
ety for Assisted Reproductive Technology (SART) guide-
lines ('SART Bulletin, 5/7/07) which is currently used for
reporting of all SART data. Embryos were assigned as
"good" (4AA, 4AB, 4BA, 5AA, 5AB, 5BA, 3AA), "fair"
(5AC, 5CA, 4AC, 4CA, 3AB, 3BA, 3BB, 3AC, 3CA, 3BC,
3CB, 3CC) or "poor" (all others). Additionally, a total
embryo quality score was calculated by adding up the
individual scores of all embryos transferred in a patient
(good = 3, fair = 2, poor = 1). Receiver Operating Charac-
teristic (ROC) analyses were used to determine the opti-
mal thickness of ES for predicting CP following BET. A
two tailed p <0.05 was considered statistically significant
and p values are reported to the third decimal place. All
analyses were performed used STATA SE v 8 (College Sta-
tion, TX).
Results and discussion
CP was observed in 50% of the BET cycles. Table 1
describes patient and ART cycle characteristics according
to cycle outcome. Continuous data are presented as mean
± standard deviation and categorical data are presented as
percentage (%). Patients achieving CP compared to NP
were significantly younger (32.4 ± 3.5 vs. 34.1 ± 4.1 years
old, p = 0.019) but had comparable ovarian reserve status
(as reflected by FSH level) and BMI values. The range of
patient ages in our cohort was 24 to 43 years. Both groups
received a similar number of blastocysts for embryo trans-
fer and had comparable embryological parameters (Table
1). There were no differences in fertilization (%) (p =
0.251) or CP by fertilization method (p = 0.364). For the
four cycles utilizing either pre-implantation genetic
screening (n = 2, recurrent pregnancy loss) or diagnosis (n
= 2, single gene disorders), the genetically normal
Table 1: Patient and cycle characteristics by pregnancy outcome
Characteristic Clinical Pregnancy Negative Pregnancy P-Value
Age (years)a 32.4 ± 3.5 34.1 ± 4.1 0.019*
BMI (kg/m2)b 24.7 ± 4.2 25.7 ± 5.2 0.573
FSH (mIU/mL)b 6.7 ± 2.3 7.1 ± 1.9 0.167
Peak E2 (pg/mL)a, c 3146.9 ± 1255.9 3498.2 ± 1267.0 0.142
Number of Eggs Retrieveda 18.4 ± 6.9 20.4 ± 7.2 0.120
Number of Mature Eggsb 15.8 ± 6.5 17.3 ± 6.4 0.176
Number of Eggs Fertilizedb 11.9 ± 4.6 12.9 ± 4.6 0.199
Number of Day 2 Embryosb 11.9 ± 4.3 12.2 ± 4.1 0.573
Number of Day 3 Embryosb 10.4 ± 3.8 10.7 ± 3.5 0.608
Number of Blastocystsb 6.6 ± 3.3 5.9 ± 2.8 0.435
Endometrial Stripe (mm)b 11.2 ± 3.1 10.1 ± 2.6 0.022*
Number of Blastocysts Transferredb 2.0 ± 0.6 2.2 ± 0.7 0.349
Number of Blastocysts Cryopreservedb 2.3 ± 2.6 1.9 ± 2.4 0.393
a T-Test bMann-Whitney U-test cdenotes estradiol value 1 day prior to oocyte retrieval
* denotes statistical significance; Data expressed as mean ± SD with n = 57 in each group.Reproductive Biology and Endocrinology 2009, 7:33 http://www.rbej.com/content/7/1/33
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embryos were either the only blastocysts that grew in cul-
ture or they were the best embryos morphologically.
Independent predictors of CP were determined by creat-
ing multivariable logistic regression models (Figure 1).
Caucasian ethnicity (OR 2.641, 95% CI 1.054–6.617, p =
0.038), thickness of ES (OR 1.185, 95% CI 1.006–1.396,
p = 0.042) and age (OR 0.879, 95% CI 0.789–0.980, p =
0.020) significantly predicted CP following BET, after
adjusting for FSH and total embryo quality score. Thick-
ness of ES and relationship of cycle outcome with ethnic-
ity were further analyzed to provide more detailed
information regarding their predictive values.
Patients achieving CP had a thicker ES on day of hCG
prior to oocyte retrieval (11.2 ± 3.1 vs. 10.1 ± 2.6 mm, p =
0.022) (Table 1). Thickness of ES was not significantly
related to patient age (r = -0.093, p = 0.336), BMI (r =
0.117, p = 0.226), FSH (r = 0.056, p = 0.561), or any of the
intermediate embryological parameters previously listed
(p > 0.05). ROC curves were constructed to evaluate pre-
dictive values of thickness of the ES; while an ES thickness
≥ 9.4 mm demonstrated a sensitivity of 83% for predicting
CP (Figure 2), area under the ROC curve was modest at
0.627, making the cutoff a poor overall indicator of suc-
cessful CP (specificity of 47%). Of the 54 clinical pregnan-
cies with known ES thickness, only 3 occurred in patients
with an ES thickness <8 mm; the other 9 patients whose
ES thickness was <8 mm did not achieve clinical preg-
nancy.
Data on ethnicity was ascertained from most patient
records by the clinician's recorded history (n = 114). The
majority of patients in both the CP and NP groups were
Caucasian (77% and 64% respectively) whereas non-Cau-
casians included East Asian, Indian (Indian subconti-
nent), Hispanic, Black (including African American and
African backgrounds), and "other" ethnicity. Caucasian
patients yielded significantly fewer blastocyst embryos
(5.9 ± 2.9 v 7.3 ± 3.3, p = 0.018) and had fewer embryos
available for cryopreservation (1.6 ± 2.3 v 3.3 ± 2.6, p <
0.001) than non-Caucasians, despite comparable ages (p
= 0.644), ovarian reserve (p = 0.892), number of prior
attempts at IVF (p = 0.408), number of mature eggs (p =
0.678), fertilized embryos (p = 0.913), and day 3 cleavage
stage embryos (p = 0.402) (Table 2). Of note, BMI was sig-
nificantly lower in Caucasian (Table 2) compared to non-
Caucasian patients. Multivariable logistic regression anal-
yses adjusting for age identified Caucasians as being sig-
nificantly less likely to be overweight, i.e. BMI 25–30 kg/
m2 (OR 0.304, 95% CI 0.130–0.715, p = 0.006) or obese,
i.e. BMI>30 kg/m2 (OR 0.261, 95% CI 0.083–0.827, p =
0.022). On univariate analyses, Caucasian patients were
more likely to achieve CP compared to non-Caucasians
(55% versus 38%), although the difference was not of sta-
tistical significance (chi-square (χ2) test, p = 0.151). Addi-
tionally, there was still no significant difference in CP
when analyzed by individual ethnicity (Fisher's Exact, p =
0.059). However, it is important to note that none of the
six Hispanic patients achieved CP (mean age 34.8 years,
BMI 32.9 kg/m2, FSH 6.7 mIU/mL). Embryo quality was
also examined in relation to ethnicity. The total embryo
quality score did not differ based on individual ethnicity
(Kruskal-Wallis, p = 0.394) or by Caucasian versus non-
Caucasian distinction (Mann-Whitney-U test, p = 0.249).
Individual ethnicity also did not impact the availability of
a "good" quality embryo for transfer (Fisher's exact, p =
0.377). Caucasians were observed to be significantly less
likely to have a "good" embryo transferred than non-Cau-
casians (65% v 85%, chi-square (χ2) test, p = 0.029).
Finally, we examined the impact of primary etiology of
infertility diagnoses on BET cycle outcome. There were no
overall differences in contributory infertility etiologies by
CP outcome (CP v NP; Fisher's Exact test, p = 0.366).
Diagnoses included: male factor (n = 27), tubal factor (n
= 28), ovulatory dysfunction (including diminished ovar-
ian reserve; n = 24), unexplained infertility (n = 21), and
other causes of infertility (endometriosis, recurrent preg-
nancy loss, neurofibromatosis, and uterine factors; n =
14). However, infertility diagnosis differed by ethnicity
(Fisher's Exact Test, p < 0.001); Caucasians were less likely
to have a diagnosis of tubal factor (15% v 66%, p < 0.001)
and more likely to have a diagnosis of "other causes of
infertility" (18% v 0%, p = 0.009, Fisher's Exact Test).
Conclusion
In this study, we have identified patient parameters that
are predictive of success of fresh BET cycles. Even among
this subset of "excellent prognosis" patients by virtue of
Multivariable logistic regression analysis showing independent  predictors of clinical pregnancy following fresh blastocyst  embryo transfer Figure 1
Multivariable logistic regression analysis showing 
independent predictors of clinical pregnancy follow-
ing fresh blastocyst embryo transfer.Reproductive Biology and Endocrinology 2009, 7:33 http://www.rbej.com/content/7/1/33
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attainment of blastocyst embryos, advancing age emerged
as a detriment to success of BET. This finding supports
much evidence in the literature of an overall detrimental
effect of aging on oocyte quality and hence, blastocyst
biology [12,13].
In addition to age, we identify thickness of ES as an inde-
pendent predictor of CP following BET; an ES thickness of
9.4 mm or greater was identified as most predictive of suc-
cessful CP in our patient sample. Prior data relating the
significance of ES thickness to pregnancy success after IVF
are mixed. Some authors report positive correlations of ES
thickness to pregnancy, [14-16], whereas others did not
find such associations [17-20]. It is worth noting that the
bulk of published literature on relationship between ES
thickness and cycle outcome focused on cycles involving
transfer of cleaving stage embryos and not blastocysts.
Our findings thus extend the previously reported observa-
tions on facilitatory implications of thickened ES on IVF
cycle outcome to BET cycles and hence provide meaning-
ful addition to the existing body of literature. Additionally
those that found significant relationships between ES and
pregnancy rates only rarely observed this to be a continu-
ous relationship, as demonstrated in our study; most have
identified a threshold thickness of ES as predictive of cycle
success. Only 2 authors specifically examined the effect of
ES on BET outcome. Zhang et al found that the detrimen-
tal effect of a thin ES on pregnancy rates was only applica-
ble to cleavage stage ET and not BET [14]. A single study
by Richter et al has specifically identified a positive rela-
tionship between thickness of ES and pregnancy after BET
[9]; the authors describe a continuous relationship
between ES thickness and CP with cutoff values of <9 mm
and ≥ 16 mm by ROC analysis; the authors acknowledge
poor specificity of ES thickness for cycle outcome, a con-
straint that is in keeping with our findings.
Approximately 30% of our patients undergoing BET were
non-Caucasian, reflecting our diverse ethnic patient pop-
ulation. In our multivariate models, Caucasians were
almost three times as likely to achieve CP despite produc-
ing fewer blastocysts available for transfer and cryopreser-
vation after adjusting for age, FSH, and number of
blastocysts transferred. Other literature supports associa-
tions between ethnicity and successful ART outcome,
although the exact nature of this association remains elu-
sive [21,22]. Previous disparities in outcome by ethnicity
despite similar patient and embryological status have sug-
gested genetic differences as a potential etiology [22].
Of note is the significantly lower BMI in the Caucasian
compared to the non-Caucasian population. In the gen-
eral U.S. population, Caucasian women have a lower BMI
and waist circumference compared to African-American
and Hispanic women [23,24]. While higher BMI may
have causative implications in the reduced likelihood of
CP observed in our non-Caucasian patients, we are unable
to explore this observed relationship further due to small
numbers of patients in each individual non-Caucasian
ethnicity. Prior ART literature suggests impaired ovarian
responses to COH as well as decreased pregnancy success
Receiver-operating characteristic analysis of thickness of ES  demonstrates a 9.5 mm cutoff best predicts CP Figure 2
Receiver-operating characteristic analysis of thick-
ness of ES demonstrates a 9.5 mm cutoff best pre-
dicts CP.
Table 2: Differences in patient and cycle characteristics by Caucasian ethnicity
Characteristic Caucasian (n = 80) Not Caucasian (n = 34) P-Value
Age (years)a 33.4 ± 3.9 33.0 ± 3.8 0.644
BMI (kg/m2)b 24.4 ± 3.9 27.1 ± 5.9 0.015*
FSH (mIU/mL)b 6.9 ± 2.3 6.9 ± 1.8 0.892
Number of Blastocystsb 5.9 ± 2.9 7.3 ± 3.3 0.018*
Endometrial Stripe (mm)b 10.6 ± 2.9 10.8 ± 2.8 0.779
Number of Blastocysts Transferredb 2.1 ± 0.7 2.0 ± 0.4 0.285
Number of Blastocysts Cryopreservedb 1.6 ± 2.3 3.3 ± 2.6 <0.001*
a T-Test bMann-Whitney U-test * denotes statistical significance
Data presented as mean ± SD. Not Caucasian ethnicity included East Asian (n = 7), Indian (n = 12) Black (n = 9), Hispanic (n = 5), and unknown (n 
= 1) patients.Reproductive Biology and Endocrinology 2009, 7:33 http://www.rbej.com/content/7/1/33
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with increasing BMI [25-27]. However, uterine receptivity
was unimpaired in women with increased BMI, when hor-
monal support and embryo quality were standardized
[28,29]. Additionally, Bellver et al. [30] found CP to be
unaffected by obesity in oocyte donor-recipient cycles but
did see an association between obesity and spontaneous
abortion. The existing data imply a link between BMI and
oocyte/embryo characteristics that is more likely to
account for the reduced clinical pregnancies seen in asso-
ciation with obesity. Interestingly, we found no overall
correlation between polycystic ovarian syndrome (PCOS)
and BMI (r = 0.024, p = 0.801); additionally PCOS was
not correlated with being overweight (r = 0.047, p =
0.620), obese (r = 0.032, p = 0.741), or Caucasian (r = -
0.010, p = 0.914). This reinforces that our patient popula-
tion overall is overweight (mean BMI 25.2 kg/m2); only
60/114 (53%) patients had a BMI < 25 kg/m2.
A longer duration of infertility prior to treatment may
lower pregnancy rates even with BET [31]. Sharara et al.
[32] previously found that African-American (compared
to Caucasian) women had a significantly longer duration
of infertility prior to seeking treatment and had a 3-fold
lower odds of achieving pregnancy. Seifer et al. [33] again
demonstrated that African-American women had a longer
duration of infertility prior to seeking treatment and were
underrepresented in IVF centers (5% of cycles) compared
to their proportion of the general population of reproduc-
tive age women (8%). It is possible that an ethnic dispar-
ity in access to ART played a role in our findings. We
believe it is especially important for future research to
document and systematically study the impact of ethnic-
ity on outcomes of fertility treatments.
Ethnic differences in the prevalence of common condi-
tions associated with infertility may also have played a
role in BET success. Ethnic variability in prevalence of
both uterine leiomyoma [34] and endometriosis is previ-
ously described [35-38] Since the diagnosis of leiomyoma
or endometriosis was only represented in our data if iden-
tified as the primary cause of infertility, it is not possible
to determine whether these conditions varied by ethnicity
and/or impacted BET success. The likelihood of a PCOS
diagnosis was comparable between Caucasian (11%) and
non-Caucasian (12%) patients, a finding common to
other published data, [39] and did not seem to impact CP
rates in our population.
We acknowledge certain limitations of our study which
prevent us from making broader conclusions. The study
was retrospective and included a relatively small sample
of patients. Ethnicity and thickness of ES though statisti-
cally significant were closer to the upper limit of signifi-
cance which most likely reflects the number of patients
included in the study. Our patients were heterogeneous
both in their underlying fertility diagnoses and by ethnic-
ity. Therefore broader implications on noted relationships
with ethnicity are limited. Both ethnicity and diagnosis
impact pregnancy rates; not all diagnoses confer the same
prognosis. Information on the duration of infertility is
lacking in our patient population.
We herein have identified differences between patients
following fresh BET; specifically, our data identify advanc-
ing age, endometrial thickness and patient's ethnicity as
independent correlates to the success of BET cycle. These
data are consistent with the previous finding that patients
achieving clinical pregnancy after BET are younger with a
thicker ES [9]. More data are needed to determine the
exact way in which ethnicity impacts on success of ART
following BET. While the past few years have allowed
insights into embryo parameters that help identify
patients who are likely to achieve embryo growth to the
blastocyst stage, our present observations indicate specific
host factors that contribute to the success of BET cycles.
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